To our knowledge, this is the first study to report the in vitro and in vivo anti-cancer efficacy of EC16-1/saporin on parental and ABCB1- and ABCG2-overexpressing cells and in mouse xenograft tumor models. The gene discussed is ABCG2; the disease is neoplasm.